Antagonistic Effects of Anti-EMMPRIN Antibody When Combined with Chemotherapy Against Hypovascular Pancreatic Cancers

PURPOSE: To examine the antagonistic effects of anti-extracellular matrix metalloprotease inducer (anti-EMMPRIN) antibody when combined with chemotherapy using a hypovascular pancreatic tumor model. PROCEDURES: Severely compromised immunodeficient mice bearing orthotopic MIA PaCa-2 tumors were used...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kim, Hyunki, Rigell, Christopher J., Zhai, Guihua, Lee, S. Kyle, Samuel, Sharon L., Martin, Amber, Umphrey, Heidi R., Stockard, Cecil R., Beasley, T. Mark, Buchsbaum, Donald J., Li, Long Shan, Boothman, David A., Zinn, Kurt R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4062967/
https://ncbi.nlm.nih.gov/pubmed/23836505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11307-013-0665-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak